Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

Safety Information

BP1083

Isoniazid

British Pharmacopoeia (BP) Reference Standard

Synonym(s):

4-Pyridinecarboxylic acid hydrazide, INH, Isonicotinic acid hydrazide, Isonicotinic hydrazide

Sign Into View Organizational & Contract Pricing

Select a Size

100 MG
¥35,500

¥35,500

Estimated to ship onMay 26, 2025

Request a Bulk Order
All Photos(1)

Select a Size

Change View
100 MG
¥35,500

About This Item

Empirical Formula (Hill Notation):
C6H7N3O
CAS Number:
54-85-3
Molecular Weight:
137.14
Beilstein:
119374
MDL number:
MFCD00006426
UNSPSC Code:
41116107
NACRES:
NA.24

¥35,500

Estimated to ship onMay 26, 2025

Request a Bulk Order

grade

pharmaceutical primary standard

API family

isoniazid

form

powder

shelf life

limited shelf life, expiry date on the label

manufacturer/tradename

BP

mp

171-173 °C (lit.)

application(s)

pharmaceutical
pharmaceutical small molecule

format

neat

storage temp.

2-8°C

SMILES string

NNC(=O)c1ccncc1

InChI

1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10)

InChI key

QRXWMOHMRWLFEY-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Isoniazid BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Isoniazid Oral Solution

    • Biochem/physiol Actions

    Antibiotic for treatment of Mycobacterium tuberculosis, inhibits mycolic acid biosynthesis. Metabolized by hepatic N-acetyltransferase (NAT) and cytochrome P450 2E1 (CYP2E1) to form hepatotoxins. Selectively induces expression of CYP2E1. Reversibly inhibits CYP2C19 and CYP3A4 activities, and mechanistically inactivates CYP1A2, CYP2A6, CYP2C19 and CYP3A4 at clinically relevant concentrations.

    Packaging

    Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

    Other Notes

    Sales restrictions may apply.

    Pictograms

    Exclamation mark
    GHS07

    Signal Word

    Warning

    Hazard Statements

    H302,H315

    Hazard Classifications

    Acute Tox. 4 Oral - Skin Irrit. 2

    Storage Class Code

    11 - Combustible Solids

    WGK

    WGK 3

    Regulatory Listings

    Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

    ISHL Indicated Name

    Substances Subject to be Indicated Names

    ISHL Notified Names

    Substances Subject to be Notified Names

    JAN Code

    BP1083:

    Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number

    It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

    If you need assistance, please contact Customer Support.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Questions

    Reviews

    No rating value

    Active Filters

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service